Brief: Fennec Pharmaceuticals Files Prospectus Relates To Possible Resale Of Up To 3.9 Million Of Common Shares
01/12/2022 21:37
Dec 1 (Reuters) - Fennec Pharmaceuticals Inc FENC.O :
* FENNEC PHARMACEUTICALS FILES PROSPECTUS RELATES TO
POSSIBLE
RESALE OF UP TO 3.9 MILLION OF COMMON SHARES FROM TIME TO TIME
BY SELLING STOCKHOLDER
Further company coverage: FENC.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Fennec Pharmaceuticals
See all newsFennec Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a share - Earnings Preview
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple